Escitalopram in adolescent major depression

MedGenMed Medscape General Medicine

Volumn 7, Issue 1, 2005, Pages

  Schaller, James L ^a   Rawlings, David B ^b  

^a Professional Medical Services of Naples   (United States)

^b Naples Community Hospital Healthcare System   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CITALOPRAM; CYTOCHROME P450; ESCITALOPRAM; FLUOXETINE; NEFAZODONE; PAROXETINE; PROPRANOLOL; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; VENLAFAXINE;

ADOLESCENT; AKATHISIA; ANHEDONIA; ANXIETY DISORDER; ARTICLE; AWARENESS; BRUXISM; CASE REPORT; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG DOSE REGIMEN; DRUG POTENTIATION; DYSTONIA; FATIGUE; FEMALE; HEADACHE; HUMAN; INTERVIEW; MAJOR DEPRESSION; MALE; MOTOR DYSFUNCTION; OBESITY; PARENT; PSYCHOPHARMACOLOGY; RESTLESSNESS; SOCIAL PHOBIA; SYMPTOMATOLOGY;

EID: 25144453320     PISSN: 15310132     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Burke WJ. Escitalopram. Expert Opinion. 2002;11:1478.
2. Psychotropics. Citalopram. Available at: http://www.psychotropics.dk/usr_view_molecule.asp Accessed July 25, 2003.
3. H. Lundbeck A/S corporation Web site. 2004. List of product trademarks. Available at: http://www.lundbeck.com/investor/Productsandmarkets/Launchedproducts/ Default.asp Accessed July 25, 2003.
4. US Food and Drug Administration. Prozac for pediatric use. Available at: http://www.fda.gov/fdac/departs/2003/203_upd.html#prozac Accessed June 13, 2004.
5. Schaller J, Behar D. Citalopram in child and adolescent depression with anxiety. Medscape General Medicine. 2001;3(4). Available at: http://www.medscape.com/viewarticle/408189 Accessed January 18, 2005.
6. MayoClinic.com. Available at: http://www.mayoclinic.com Accessed January 18, 2005.
7. Zimmerman M, Coryell W. The validity of a self-report questionnaire for diagnosing major depressive disorder. Arch Gen Psychiatry. 1988;45:738-740.
8. Bandelow B, Behnke K, Lenoir S, et al. Sertraline versus paroxetine in the treatment of panic disorder: an acute, double-blind noninferiority comparison. J Clin Psychiatry. 2004;65:405-413.
9. Schaller JL. Celexa and Lexapro vs regular SSRI's. Available at: http://www.personalconsult.com/articles/ssricme1.html Accessed June 2, 2004.
10. Greenblatt DJ, von Moltke LL, Harmatz JS, Shader RI. Human cytochromes and some newer antidepressants: kinetics, metabolism, and drug interactions. J Clin Psychopharmacol. 1999;19:23S-35S.
11. von Moltke LL, Greenblatt DJ, Giancarlo GM, Granda BW, Harmatz JS, Shader RI. Escitalopram (S-citalopram) and its metabolites in vitro: cytochromes mediating biotransformation, inhibitory effects, and comparison to R-citalopram. Drug Metab Dispos. 2001;29:1102-1109.
12. Greenblatt DJ, Hesse LM, Giancarlo GM, Harmatz JS, Shader RI. The S-entantiomer of citalopram: cytochromes P450 mediating metabolism and cytochrome inhibitory effects. Program and abstracts of the 56th Annual Scientific Convention of the Society of Biological Psychiatry; May 3-5, 2001; New Orleans, Louisiana.
13. Sanchez C, Brennum L. Escitalopram is a highly selective and potent serotonin reuptake inhibitor. In vitro studies. Program and abstracts of the 1st Annual Meeting of the Scandinavian College of Neuropsychopharmacology; April 18-20, 2001; Juan-Les-Pins, France.
14. Gorman JM, Korotzer A, Su G. Efficacy comparison of escitalopram and citalopram in the treatment of major depressive disorder: pooled analysis of placebo-controlled trials. CNS Spectr. 2002;7:40-44.
15. Fish EW, Faccidomo S, Gupta S, Miczek KA. Anxiolytic-like effects of escitalopram, citalopram, and R-citalopramin maternally separated mouse pups. J Pharmacol Exp Ther. 2004;308:474-480.
16. Stahl SM, Gergel I, Li D. Escitalopram in the treatment of panic disorder: a randomized, double-blind, placebo-controlled trial. J Clin Psychiatry. 2003;64:1322-1327.